| Type | Period | Ended | Filed | |
|---|---|---|---|---|
| 10-K | FY 2025 | 12/31/25 | 2/20/26 | → |
| 10-Q | Q3 2025 | 9/30/25 | 10/29/25 | → |
| 10-Q | Q2 2025 | 6/30/25 | 7/30/25 | → |
| 10-Q | Q1 2025 | 3/31/25 | 4/30/25 | → |
| 10-K | FY 2024 | 12/31/24 | 2/21/25 | → |
| 10-Q | Q3 2024 | 9/30/24 | 10/31/24 | → |
| ↓ | ||||
| Filed | Period | |
|---|---|---|
| 1/22/26 | Q4 FY2026 | → |
| 10/15/25 | Q3 FY2025 | → |
| 7/17/25 | Q2 FY2025 | → |
| 4/16/25 | Q1 FY2025 | → |
| 1/22/25 | Q4 FY2025 | → |
| 10/16/24 | Q3 FY2024 | → |
| ↓ | ||
| Filed | Type | Description | |
|---|---|---|---|
| 3/9/26 | Agreement | Entry into a Material Definitive Agreement | → |
| 2/26/26 | Agreement | Entry into a Material Definitive Agreement | → |
| 2/20/26 | Other | Amendments to Articles of Incorporation or Bylaws | → |
| 12/12/25 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| 11/21/25 | Other | 8-K Filing | → |
| 11/20/25 | Agreement | Entry into a Material Definitive Agreement | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 2/25/26 | 424B5 | 424B5 | → |
| 2/24/26 | FWP | FWP | → |
| 2/23/26 | 424B3 | 424B3 | → |
| 2/23/26 | S-3ASR | S-3ASR | → |
| 3/14/25 | ARS | ANNUAL REPORT TO SECURITY HOLDERS | → |
| 3/15/24 | ARS | ANNUAL REPORT TO SECURITY HOLDERS | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/14/25 | DEFA14A | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | → |
| 3/14/25 | DEF 14A | DEFINITIVE PROXY STATEMENT | → |
| 3/15/24 | DEFA14A | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | → |
| 3/15/24 | DEF 14A | DEFINITIVE PROXY STATEMENT | → |
| 3/17/23 | DEFA14A | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | → |
| 3/17/23 | DEF 14A | DEFINITIVE PROXY STATEMENT | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/2/26 | 144 | 144 | → |
| 3/2/26 | 144 | 144 | → |
| 3/2/26 | 144 | 144 | → |
| 3/2/26 | 144 | 144 | → |
| 3/2/26 | 144 | 144 | → |
| 3/2/26 | 144 | 144 | → |
| ↓ | |||
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.